Global assembling of Academicians, Researchers, Scholars & Industry to disseminate and exchange information at 100+ Allied Academics Conferences
Doctor Dinesh Kansal working as an professor and HOD in the Department of Pharmacology at Dr. Rajendra prasad Government Medical College Kangra.He has completed his graduation M.B.B.S in the year 1983 at Himachal Pradesh University, Shimla H.P. He has done his masters degree in the year 1998 at Himachal Pradesh University, Shimla H.P. He has teaching experience from past 28 years. His area of interest in Neuro pharmacology, Experimental and Analytical Pharmacology,Clinical Pharmacology,Pharmacovigilance. He has published the 28 Research Papers in International / National Journals.He got an award Bharat Vidya Rattan award by International Business Council, New Delhi. He has Organized CME on Pharmacovigilance at Dr. RPGMC Kangra at Tanda in October 2013.Organized CME on Haemovigilance at Dr. RPGMC Kangra at Tanda in April 2014. He was invited as an Chairperson at 46th Annual Conference of Indian Pharmacological Society on 16th to 18th December, 2013 at Bengaluru. Chairperson at 2nd International & 5th National Conference of Indian Society for Rational Pharmacotherapeutics on 30th January to 1st Feburary, 2014 at DMC Ludhiana. Chairperson at International Conference of Pharmacology & Drug Discovery on “Pharmacology for Future: Towards Translational Approach for Next Generation Pharmacologists” at Maharaja Agrasain University. He was coordinated in Coordinator of Adverse drug reaction monitoring Centre, Pharmacovigilance Program of India, Indian Pharmacopoeia Commission, Ghaziabad U.P under the aegis of Ministry of Health and Family Welfare, Government of India. Chairperson Institutional Prescription audit Committee. Chairperson of Institutional Animal Ethics Committee of Dr. RPGMC Tanda H.P, Editor in chief Indian Journal of Pharmacy and Pharmacology. Member Institutional Disciplinary Committee. He was an Research Guidant to M.D Students Since 2011.
Background: Adverse drug events can lead to admission in hospital, prolongation of hospitalisation, increase in investigation and treatment costs, deformities, danger to life and even death. Methods: A retrospective analytical study was conducted of adverse drug reaction (ADR) reports collected in our ADR Monitoring Centre established in Pharmacology Department under the Aegis of Indian Pharmacopoeia Commission (IPC) Ghaziabad (MINISTRY OF Health & Family Welfare, Govt. of India). Data pertained to the period from March 2015 to March, 2018. Results: A total of 1059 reports were analysed. 568(54%) patients were females and 491(46%) were males. The majority of ADRs were due to Cancer Chemotherapy agents in 493(46.5%) patients, followed by 182(17%) in HIV patients, and 162(15%) in T.B. patients. 726(68.5%) patients recovered completely at the time filling up of form, 328(31%) were recovering and 5 patients died. 3 deaths were of snake bitecases and 2 deaths were of MDR TB cases. Conclusion: Awareness and timely intervention in case of ADR can save many precious lives.